Group 1 - The core viewpoint of the news is that Weisi Medical's stock has experienced fluctuations, with a year-to-date increase of 78.09% and a recent decline of 2.03% on December 26 [1] - As of December 26, Weisi Medical's stock price is 48.28 yuan per share, with a market capitalization of 4.624 billion yuan [1] - The company has seen a net outflow of 5.3064 million yuan in principal funds, with significant trading activity reflected in the buying and selling of large orders [1] Group 2 - Weisi Medical, established on January 10, 2001, specializes in the research, production, and sales of rehabilitation medical devices, focusing on areas such as pelvic floor and postpartum rehabilitation, neurological rehabilitation, and mental rehabilitation [2] - The company's revenue composition includes magnetic stimulation (39.44%), consumables and accessories (19.42%), electrophysiology (19.18%), laser radiofrequency (10.26%), electrical stimulation (8.42%), and others (3.28%) [2] - For the period from January to September 2025, Weisi Medical achieved a revenue of 326 million yuan, representing a year-on-year growth of 11.58%, and a net profit attributable to shareholders of 102 million yuan, with a year-on-year increase of 30.68% [2]
伟思医疗跌2.03%,成交额6203.16万元,主力资金净流出530.64万元